Data gathered: March 28
AI Stock Analysis - Astrazeneca (AZN)
Analysis generated November 27, 2024. Powered by Chat GPT.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company operates in various therapeutic areas, including oncology, cardiovascular, renal & metabolism, respiratory, and immunology. AstraZeneca has a strong presence in over 100 countries, and its innovative medicines are used by millions of patients worldwide.
Stock Alerts - Astrazeneca (AZN)
 |
Astrazeneca | March 17 News Alert: AstraZeneca to acquire EsoBiotec for $425M upfront |
|
Astrazeneca | February 11 Over the past few months, there has been an downward trend in Web Traffic. |
|
Astrazeneca | January 16 News Alert: AstraZeneca PLC Sued for Securities Law Violations - Contact The Gross Law Firm Before February 21, 2025 to Discuss Your Rights – AZN |
|
Astrazeneca | January 9 News Alert: ASTRAZENECA SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AstraZeneca PLC - AZN |
Alternative Data for Astrazeneca
About Astrazeneca
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.
| Price | $73.79 |
| Target Price | Sign up |
| Volume | 3,430,000 |
| Market Cap | $227B |
| Year Range | $62.32 - $86.4 |
| Dividend Yield | 2.13% |
| PE Ratio | 32.32 |
| Analyst Rating | 100% buy |
| Industry | Drug Manufacturers |
In the news
 |
Brokers Suggest Investing in Astrazeneca (AZN): Read This Before Placing a BetMarch 26 - Yahoo |
|
Astrazeneca (AZN) Stock Moves -0.45%: What You Should KnowMarch 26 - Yahoo |
 |
Brokerages Set AstraZeneca PLC (LON:AZN) PT at GBX 7,542.80March 23 - ETF Daily News |
|
Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A DealsMarch 21 - Yahoo |
 |
Independent Advisor Alliance Purchases 442 Shares of AstraZeneca PLC (NASDAQ:AZN)March 20 - ETF Daily News |
|
Wealthfront Advisers LLC Acquires New Position in AstraZeneca PLC (NASDAQ:AZN)March 18 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '24 | 14.9B | 2.73B | 12.2B | 1.5B | 4.43B | 1.045 |
| Q3 '24 | 13.6B | 3.08B | 10.5B | 1.43B | 4.1B | 0.457 |
| Q2 '24 | 12.9B | 2.18B | 10.8B | 1.93B | 4.12B | 0.990 |
| Q1 '24 | 12.7B | 2.22B | 10.5B | 2.18B | 4.57B | 1.030 |
| Q4 '23 | 12B | 2.31B | 9.72B | 960M | 2.18B | 0.730 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$163.71 0.4% | 53 |
 |
Eli Lilly and CompanyLLY |
$822.51 0.1% | 73 |
 |
PfizerPFE |
$25.21 0.8% | 38 |
 |
AbbVieABBV |
$205.29 1.3% | 54 |
 |
TherapeuticsMDTXMD |
$0.98 6.7% | 37 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
| Michael McCaul Republican |
Sep 20, 23 | Sell | $100K - $250K |
| Michael McCaul Republican |
Sep 20, 23 | Sell | $50K - $100K |
Read more about Astrazeneca (AZN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Astrazeneca?
The Market Cap of Astrazeneca is $227B.
What is Astrazeneca's PE Ratio?
As of today, Astrazeneca's PE (Price to Earnings) ratio is 32.32.
What is the current stock price of Astrazeneca?
Currently, the price of one share of Astrazeneca stock is $73.79.
How can I analyze the AZN stock price chart for investment decisions?
The AZN stock price chart above provides a comprehensive visual representation of Astrazeneca's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Astrazeneca shares. Our platform offers an up-to-date AZN stock price chart, along with technical data analysis and alternative data insights.
Does AZN offer dividends to its shareholders?
Yes, Astrazeneca (AZN) offers dividends to its shareholders, with a dividend yield of 2.13%. This dividend yield represents Astrazeneca's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Astrazeneca in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Astrazeneca?
Some of the similar stocks of Astrazeneca are Johnson & Johnson, Eli Lilly and Company, Pfizer, AbbVie, and TherapeuticsMD.
.